Featured Press Releases

Mercury Bio

Mercury Bio's new project includes Los Alamos and the National Center for Genome Resources.

ImmPACT Bio announces FDA clearance of its IND application for CD19/CD20 bispecific CAR-T cell therapy in multiple sclerosis

ImmPACT Bio announces FDA clearance of its IND application for CD19/CD20 bispecific CAR-T cell therapy in multiple sclerosis

  • 21 Aug 2024

ImmPACT Bio USA Inc.a clinical-stage biopharmaceutical company developing a new generation of...

Theravance Biopharma completes enrollment in Phase 3 CYPRESS study of Ampreloxetine for neurogenic orthostatic hypotension

Theravance Biopharma completes enrollment in Phase 3 CYPRESS study of Ampreloxetine for neurogenic orthostatic hypotension

The MosaiQ AiPlex® Vasculitis assay is now available for clinical use in the European Union and other countries accepting the CE mark

The MosaiQ AiPlex® Vasculitis assay is now available for clinical use in the European Union and other countries accepting the CE mark

LOTUS study data on DAYBUE® (trofinetide) for Rett Syndrome

LOTUS study data on DAYBUE® (trofinetide) for Rett Syndrome's long-term efficacy and tolerability is published in Developmental Medicine and Child Neurology

Real-world data presented at TCT 2025 demonstrates that the EggNest™ Complete Radiation Protection System significantly reduces radiation exposure for the entire cath lab

Real-world data presented at TCT 2025 demonstrates that the EggNest™ Complete Radiation Protection System significantly reduces radiation exposure for the entire cath lab

ProductLife Group Appoints Dr. James Burt as CEO

ProductLife Group Appoints Dr. James Burt as CEO

  • ProductLife Group
  • 24 Mar 2026
Constance Sabbagh Appointed as General Manager as Avanzanite Expands French Operations

Constance Sabbagh Appointed as General Manager as Avanzanite Expands French Operations

  • Avanzanite Bioscience B.V.
  • 24 Mar 2026
Emerging From Stealth, Oryon Cell Therapies Targets Autologous Neuron Replacement for Parkinson’s Disease and Neurodegenerative Disorders

Emerging From Stealth, Oryon Cell Therapies Targets Autologous Neuron Replacement for Parkinson’s Disease and Neurodegenerative Disorders

  • Oryon Cell Therapies
  • 23 Mar 2026
Samsung Biologics Labor Union Warns of

Samsung Biologics Labor Union Warns of "Structural Supply Chain Risk" Amid Labor Dispute, Citing Systemic Governance Failures

  • Samsung Biologics Labor Union
  • 23 Mar 2026
Convergent Therapeutics Appoints Michael Rossi to Board

Convergent Therapeutics Appoints Michael Rossi to Board

  • Convergent Therapeutics Inc.
  • 20 Mar 2026
Johnson & Johnson Announces U.S. Food and Drug Administration Approval of TECVAYLI + DARZALEX FASPRO for Relapsed/Refractory Multiple Myeloma.

Johnson & Johnson Announces U.S. Food and Drug Administration Approval of TECVAYLI + DARZALEX FASPRO for Relapsed/Refractory Multiple Myeloma.

  • Johnson & Johnson
  • 06 Mar 2026
World Drug Delivery Summit 2025
The Digital Pharma Advances Conference 2026

Most Popular
March   2026
M T W T F S S
            1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31          

User Area

Discover

Engage with Us

© Pharmaceutical Era — A product of HISSM. All Rights Reserved.